miR-210 overexpression increases pressure overload-induced cardiac fibrosis

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• MicroRNA Research

Background:

• Aortic stenosis causes left ventricular pressure overload, leading to pro-fibrotic cardiac remodeling.
• MicroRNA-210 (miR-210) is implicated in cardiac response to hypoxia, ischemia, and myocardial infarction.

Purpose of the Study:

• To investigate the role of miR-210 in cardiac fibrosis and remodeling induced by pressure overload.

Main Methods:

• Utilized a mouse model with inducible miR-210 overexpression subjected to transverse aortic constriction (TAC).
• Assessed cardiac structure, function, gene expression (Nppa, Nppb), inflammation, fibrosis, and myofibroblast activation.
• Conducted in vitro studies on cardiac fibroblasts overexpressing miR-210.

Main Results:

• miR-210 overexpression induced eccentric hypertrophy, increased cardiomyocyte size, and heightened hypertrophic markers.
• Observed exacerbated cardiac inflammation, interstitial/perivascular fibrosis, and myofibroblast activation.
• In vitro, miR-210 enhanced fibroblast adhesion, wound healing, and migration; promoted angiogenesis.

Conclusions:

• miR-210 significantly contributes to adverse cardiac remodeling under pressure overload conditions.
• miR-210 worsens cardiac dysfunction, inflammation, and fibrosis, suggesting it as a potential therapeutic target.